KATHERINE WILKINS: Open Payments
NPI 1700950334 · SUNNYVALE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,423 in 69 payments from 21 companies in 2025. Trend: 2023 $1,313 · 2024 $1,216 · 2025 $1,423
Food & beverage: $1,423
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $205 |
| PFIZER INC. | 10 | $203 |
| AstraZeneca Pharmaceuticals LP | 6 | $179 |
| GlaxoSmithKline, LLC. | 6 | $103 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $95 |
| Abbott Laboratories | 4 | $92 |
| Lilly USA, LLC | 5 | $81 |
| SANOFI-AVENTIS U.S. LLC | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| Astellas Pharma US Inc | 3 | $46 |
Products named: FARXIGA, JARDIANCE, Ozempic, PREVNAR 20, FREESTYLE LIBRE 3, TZIELD, Wegovy, MOUNJARO.
Industry payments across TX — which companies pay providers there.
